Revance Therapeutics Inc. buy quelbe60
Start price
29.11.24
/
50%
€3.42
Target price
29.11.25
-
Performance (%)
3.51%
End price
05.12.24
€3.54
Summary
This prediction ended on 05.12.24 with a price of €3.54. With a performance of 3.51%, the BUY prediction by quelbe60 for Revance Therapeutics Inc. closed with a slight gain. quelbe60 has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Revance Therapeutics Inc. | - | - | - |
| iShares Core DAX® | 0,22 % | 1,49 % | 3,58 % |
| iShares Nasdaq 100 | 6,05 % | 16,19 % | 39,14 % |
| iShares Nikkei 225® | 5,72 % | 11,69 % | 50,96 % |
| iShares S&P 500 | 2,17 % | 8,06 % | 25,62 % |
According to quelbe60 what are the pros and cons of Revance Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by quelbe60 for this prediction
In the thread Revance Therapeutics Inc. diskutieren
Buy Revance Therapeutics Inc.